Tissue factor activity in whole blood

Blood

Volumn 105, Issue 7, 2005, Pages 2764-2770

  Butenas, Saulius ^a   Bouchard, Beth A ^a   Brummel Ziedins, Kathleen E ^a   Parhami Seren, Behnaz ^a   Mann, Kenneth G ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IONOPHORE; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; THROMBOPLASTIN;

ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; CELL FRACTIONATION; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HEMOSTASIS; HUMAN; IMMUNOASSAY; MALE; METASTASIS POTENTIAL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; THROMBOCYTE ACTIVATION;

EID: 15944404600     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-09-3567     Document Type: Article

References (59)

1. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097.
2. Fleck RA, Rao LV, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res. 1990;59:421-437,
3. Eddleston M, de la Torre JC, Oldstone MB, Loskutoff DJ, Edgington TS, Mackman N. Astrocytes are the primary source of tissue factor in the murine central nervous system: a role for astrocytes in cerebral hemostasis. J Clin Invest. 1993;92:349-358.
4. 1+2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation. Am J Hematol. 1997;56:5-11.
5. Nijziel M, van Oerle R, van't Veer C, van Pampus E, Lindhout T, Hamulyak K. Tissue factor activity in human monocytes is regulated by plasma: implications for the high and low responder phenomenon. Br J Haematol, 2001;112:98-104,
6. Broussas M, Cornillet-Lefebvre P, Potron G, Nguyen P, Adenosine inhibits tissue factor expression by LPS-stimulated human monocytes: involvement of the A3 adenosine receptor. Thromb Haemost. 2002;88:123-130.
7. Rickles FR, Kreutzer DL. In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes. Am J Pathol. 1994;145:1315-1322.
8. Kubota T, Andoh K, Sadakata H, Tanaka H, Kobayashi N. Tissue factor released from leukemic cells. Thromb Haemost. 1991;65:59-63.
9. Edwards RL, Rickles FR, Cronlund M. Abnormalities of blood coagulation in individuals with cancer: mononuclear cell tissue factor generation. J Lab Clin Med. 1981;98:917-928.
10. Spicer EK, Norton R, Bloem L, et al. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A. 1987;84:5148-5152.
11. Ruf W, Rehemtulla A, Morrissey JH, Edgington TS. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem. 1991 ;266:2158-2166.
12. Fiore MM, Neuenschwander PF, Morrissey JH. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa. J Biol Chem. 1994;269:143-149.
13. Komiyama Y, Pedersen AH, Kisiel W, Proteolytic activation of factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor. Biochemistry. 1990;29:9418-9425.
14. Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JWA, Radder JK. Elevated numbers of tissue factor-exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation, 2002;106:2442-2447.
15. Berckmans RJ, Nieuwland R, Tak PP, et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum. 2002;46:2857-2866.
16. Siddiqui FA, Desai H, Amirkhosravi A, Amaya M, Francis JL. The presence and release of tissue factor from human platelets. Platelets, 2002;13:247-253.
17. Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA. 1999;96:2311-2315.
18. Takahashi H, Satoh N, Wada K, Takakuwa E, Seki Y, Shibata A. Tissue factor in plasma of patients with disseminated intravascular coagulation. Am J Hematol. 1994:46:333-337.
19. Balasubramanian V, Grabowski E, Bini A, Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood. 2002;100:2787-2792.
20. So AK, Varisco P-A, Kemkes-Matthes B, et al. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost. 2003;1:2510-2515.
21. Santucci RA, Erlich J, Labriola J, et al. Measurement of tissue factor activity in whole blood. Thromb Haemost. 2000;83:445-454.
22. Berckmans RJ, Nieuwland R, Boing AN, Romijn FPHTM, Hack CE, Sturk A. Cell-derived micro-particles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost. 2001;85:639-646.
23. Butenas S, Mann KG. Active tissue factor in blood? Nat Med. 2004;10:1155-1156.
24. Day SM, Reeve JL, Pedersen B, el al. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood. 2005;105:192-198,
25. Rand MD, Lock JB, van't Veer C, Gaffney DP, Mann KG. Blood clotting in minimally altered whole blood. Blood. 1996;88:3432-3445.
26. Cawthern KM, van't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood. 1998;91:4581-4592,
27. Brummel KE, Paradis SG, Butenas S, Mann KG. Thrombin functions during tissue factor-induced blood coagulation. Blood. 2002;100:148-152.
28. Peyrou V, Lormeau JC, Herault JP, Gaich C, Pfliegger AM, Herbert JM. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost. 1999;81:400-406.
29. He R, Xiong S, He X, et al, The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway. Thromb Haemost. 2001;85:1055-1059.
30. Keularts IMLW, Zivelin A, Seligsohn U, Hemker HC, Beguin S. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost. 2001;85:1060-1065.
31. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med. 2002;8:1175-1179.
32. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med. 2003;9:458-462.
33. Lawson JH, Kalafatis M, Stram S, Mann KG. A model for the tissue factor pathway to thrombin, I: an empirical study. J Biol Chem. 1994;269:23357-23366.
34. van't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofaclor-II. J Biol Chem. 1997;272:4367-4377.
35. Bajaj SP, Rapaport SI, Prodanos C. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem. 1981;11:397-412.
36. Katzmann JA, Nesheim ME, Hibbard LS, Mann KG. Isolation of functional human coagulation factor V by using a hybridoma antibody. Proc Natl Acad Sci USA. 1981;78:162-166.
37. Griffith MJ, Noyes CM, Church FC. Reactive site peptide structural similarity between heparin co-factor II and antithrombin III. J Biol Chem. 1985;260:2218-2225.
38. Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspension of washed platelets from humans. Br J Haematol. 1972;22:193-204.
39. Higgins DL, Mann KG. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J Biol Chem. 1983;258:6503-6508.
40. Hojima Y, Pierce JV, Pisano JJ. Hageman factor fragment inhibitor in corn seeds: purification and characterization. Thromb Res. 1980;20:149-162.
41. Butenas S, Ribarik N, Mann KG. Synthetic substrates for human factor VIIa and factor VIIa-tissue factor. Biochemistry. 1993;32:6531-6538.
42. Reeve JL, Day SM, Fay WP. Quantitative comparison of circulating vs vascular wall tissue factor activity [abstract]. Blood. 2003;102:551-552. Abstract 2025.
43. Bach R, Jilma B, Mayr F, et al. Time course of tissue factor procoagulant activity increases on mononuclear cells and platelets following endotoxin-induced systemic inflammation in humans [abstract]. Blood. 2003;102:551. Abstract 2023.
44. Aras O, Shet A, Bach RR, et al. Induction of microparticle and cell-associated intravascular tissue factor in human endotoxemia. Blood. 2004;103:4545-4553.
45. Parhami-Seren B, Butenas S, Bouchard B, Amblo J, Mann KG, Quantitation of natural, recombinant, cell-surface, and plasma tissue factor [abstract]. Blood, 2004;104:533, Abstract 1929.
46. Ozcan M, Morton CT, Solovey A, et al. Whole blood tissue factor procoagulant activity remains detectable during severe aplasia following bone marrow and peripheral blood stem cell transplantation. Thromb Haemost. 2001;85:250-255.
47. Camera M, Frigerio M, Toschi V, et al. Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs. Arterioscler Thromb Vasc Biol. 2003;23:1690-1696.
48. Grundt H, Hetland O, Nilsen DW. Changes in tissue factor and activated factor XII following an acute myocardial infarction were uninfluenced by high doses of n-3 polyunsaturated fatty acids. Thromb Haemost. 2003;89:752-759.
49. Kopp CW, Steiner S, Priglinger U, et al. Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct anti-thrombotic-drug regimen in coronary artery stenting. Blood Coagul Fibrinolysis. 2003;14:379-386.
50. Ruf W, Rehemtulla A, Edgington TS. Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem J. 1991;278:729-733.
51. Sambola A, Osende J, Hathcock J, et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation. 2003;107:973-977.
52. Balasubramanian V, Vele O, Nemerson Y. Local shear conditions and platelet aggregates regulate the incorporation and activity of circulating tissue factor in ex-vivo thrombi. Thromb Haemost. 2002;88:822-826,
53. Sase T, Wada H, Nishioka J, et al. Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases. Thromb Haemost. 2003;89:660-665,
54. Neuenschwander PF, Morrissey JH. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not co-factor function: analysis of a mutant with a selective deficiency in activity. J Biol Chem. 1992;267:14477-14482.
55. Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med. 2003;197:1585-1598.
56. Undas A, Brummel K, Musial J, Mann KG, Szczeklik A. Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood. 2001;98:2423-2431.
57. Tuszynski GP, Bevacqua SJ, Schmaier AH, Colman RW, Walsh PN. Factor XI antigen and activity in human platelets. Blood. 1982;59:1148-1156.
58. Butenas S, Dee JD, Mann KG. The function of factor XI in tissue factor-initiated thrombin generation. J Thromb Haemost. 2003;1:2103-2111.
59. Mann KG, Bovill EG, Krishnaswamy S. Surface-dependent reactions in the propagation phase of blood coagulation. Ann NY Acad Sci. 1991;614:63-75.